Lumos Pharma, Inc. (LUMO)
Dec 12, 2024 - LUMO was delisted (reason: acquired by Double Point Ventures)
4.340
0.00 (0.00%)
Inactive · Last trade price
on Dec 11, 2024
Lumos Pharma Analyst Ratings
Total Analysts
4
Consensus Rating
Buy
Price Target
$9.38
Upside
+116.13%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $4.25 | Hold | Reiterates | $4.25 | -2.07% | Nov 8, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades $28 → $4.25 | Strong Buy → Hold | Downgrades | $28 → $4.25 | -2.07% | Oct 24, 2024 |
| Jones Trading | Jones Trading | Strong Buy → Hold Downgrades $20 → $4.25 | Strong Buy → Hold | Downgrades | $20 → $4.25 | -2.07% | Oct 23, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $28 | Strong Buy | Reiterates | $28 | +545.16% | Sep 27, 2024 |
| EF Hutton | EF Hutton | Strong Buy Initiates $16 | Strong Buy | Initiates | $16 | +268.66% | Sep 24, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $16 → $13 | Buy | Maintains | $16 → $13 | +199.54% | Aug 2, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $28 | Strong Buy | Reiterates | $28 | +545.16% | Mar 20, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $28 | Strong Buy | Reiterates | $28 | +545.16% | Mar 8, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $16 | Buy | Maintains | $16 | +268.66% | Mar 8, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $17 → $16 | Buy | Maintains | $17 → $16 | +268.66% | Dec 11, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $28 | Strong Buy | Reiterates | $28 | +545.16% | Dec 7, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $28 | Strong Buy | Reiterates | $28 | +545.16% | Sep 6, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $10 | Buy | Reiterates | $10 | +130.41% | Aug 22, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $14 → $10 | Buy | Maintains | $14 → $10 | +130.41% | Aug 15, 2023 |
| Oppenheimer | Oppenheimer | Buy Maintains $18 → $17 | Buy | Maintains | $18 → $17 | +291.71% | Aug 10, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $28 | Strong Buy | Reiterates | $28 | +545.16% | Aug 10, 2023 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.